Astrana Health (NASDAQ:ASTH) Coverage Initiated by Analysts at TD Cowen

TD Cowen began coverage on shares of Astrana Health (NASDAQ:ASTH) in a research note issued to investors on Monday, Marketbeat reports. The brokerage issued a buy rating and a $66.00 price objective on the stock.

ASTH has been the topic of several other research reports. KeyCorp initiated coverage on Astrana Health in a report on Friday. They set a sector weight rating on the stock. Stifel Nicolaus lifted their price objective on Astrana Health from $48.00 to $60.00 and gave the stock a buy rating in a research report on Thursday, August 1st. Robert W. Baird upped their target price on shares of Astrana Health from $54.00 to $67.00 and gave the company an outperform rating in a research report on Thursday, August 15th. Truist Financial lifted their price target on shares of Astrana Health from $50.00 to $59.00 and gave the stock a buy rating in a research report on Friday, August 9th. Finally, BTIG Research increased their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a buy rating in a report on Thursday, October 3rd. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Astrana Health currently has an average rating of Buy and a consensus target price of $62.00.

Astrana Health Trading Up 6.1 %

Shares of ASTH opened at $59.64 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.84 and a current ratio of 1.84. The company has a market cap of $3.34 billion, a price-to-earnings ratio of 45.18, a PEG ratio of 2.20 and a beta of 1.21. The stock has a fifty day moving average price of $52.01 and a two-hundred day moving average price of $45.34. Astrana Health has a 52-week low of $28.86 and a 52-week high of $61.51.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The business had revenue of $486.30 million for the quarter, compared to the consensus estimate of $440.68 million. During the same quarter in the prior year, the company earned $0.28 EPS. The firm’s quarterly revenue was up 39.7% on a year-over-year basis. Analysts predict that Astrana Health will post 1.33 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. SG Americas Securities LLC acquired a new stake in Astrana Health in the third quarter worth $680,000. Handelsbanken Fonder AB bought a new stake in shares of Astrana Health in the 3rd quarter valued at $492,000. Granite Bay Wealth Management LLC acquired a new stake in Astrana Health during the 3rd quarter worth $290,000. Central Pacific Bank Trust Division bought a new position in Astrana Health during the third quarter worth about $160,000. Finally, GAMMA Investing LLC acquired a new position in Astrana Health in the third quarter valued at about $34,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.